CRVO
CervoMed Inc. · NASDAQ
- Sector Commercial Services
- Industry Miscellaneous Commercial Services
- Website cervomed.com
- Employees(FY) 4
- ISIN US15713L1098
Performance
+0.79%
1W
-3.06%
1M
+43.56%
3M
+144.32%
6M
+215.73%
YTD
+322.63%
1Y
Profile
CervoMed Inc., a clinical-stage biotechnology company, engages in the development and commercialization of drug treatments for neurodegenerative diseases. It develops neflamapimod, an orally administered small molecule brain penetrant for the treatment of dementia with Lewy bodies (DLB), Alzheimer's diseases, and brain stroke recovery. The company is based in Boston, Massachusetts.
Technical Analysis of CRVO 2024-05-10
Overview:
In analyzing the technical indicators for CRVO over the last 5 days, we will delve into the trend, momentum, volatility, and volume indicators to provide a comprehensive outlook on the possible stock price movement in the coming days. By examining these key indicators, we aim to offer valuable insights and predictions to guide investme...
Recent News & Updates
- 2024-05-14 21:54
- 2024-05-14 20:00
- 2024-04-02 19:00
- 2024-04-01 19:00
- 2024-03-31 20:00
- 2024-03-28 04:05
CervoMed to Participate in Upcoming Investor Conferences(Globenewswire)
- 2024-03-27 20:30
- 2024-03-04 19:00
- 2024-02-20 19:00
- 2024-02-19 21:22
- 2024-02-11 19:00
- 2024-02-06 19:30
- 2024-02-06 18:00
- 2024-02-05 18:00
- 2024-02-04 19:00
CervoMed to Participate in the Emerging Growth Conference 67(Globenewswire)
- 2024-01-09 18:00
- 2024-01-08 18:00
- 2024-01-04 19:00
CervoMed to Participate in the Emerging Growth Conference 66(Globenewswire)
- 2023-11-12 18:00
- 2023-10-29 23:21
CRVO: New Data from Phase 2a Trial Presented at CTAD(Yahoo Finance)
- 2023-10-25 02:50
- 2023-10-23 19:00
- 2023-10-17 19:00
- 2023-10-04 19:00
- 2023-09-17 22:40
- 2023-09-04 19:00
- 2023-08-20 20:16
- 2023-08-15 04:01
- 2023-03-29 19:00
- 2022-12-15 17:30
Page 1 of 4
previousnext